Genworth Financial, Inc. (GNW) Stock | GNW Stock Price & Analysis

Feed

GNW

Genworth Financial, Inc. GNW · NYSE

$8.95 -1.38% (-$0.13)

Summary

47 / 100 · Bulios Score

Valuation 87Growth 17Profitability 9Quality 16Debt 100Stability 70

What speaks for it

It bought back its own shares for $319.0M in the last fiscal year, 9.3% of its market value.
It has been profitable 6 years in a row.

What to watch

Earnings per share fell by 23% a year over the last 3 years.
Out of every 100 USD of revenue, only 3.0 USD is left as net profit.
It missed profit estimates 5 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Is it expensive?

Fairly priced

Bulios Fair Price

Current price $8.95

5-year average P/E 14.8 8.8% higher

P/E today 16.1

Insurance - Diversified industry median

P/E today 16.1

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 16.1 USD for 1 USD of yearly profit. Over the last five years it was 14.8 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

7.6B

7.4B

7.1B

6.4B

6.1B

5.8B

2021202220232024202520262027

Diluted EPS (USD)

$1.76

$1.19

$0.16

$0.68

$0.54

$1.10

$1.13

2021202220232024202520262027

Analyst estimate

Revenue fell by 5.0% a year over 5 years. Over the last 3 years it fell by 4.9% a year. Earnings per share fell by 23% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 USD of revenue goes

Cost of sales 59 USD
Sales and administration 35 USD
Taxes and other 2.7 USD
Net profit 3.0 USD

Net profit, industry median (Insurance - Diversified) 8.3 USD

Out of every 100 USD of revenue, 3.0 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.

Financial health in detail

Does it pay a dividend?

It pays no dividend.

Dividends in detail

What do analysts expect?

Neutral

Buy 3
Hold 12
Sell 2

No analyst has published a price target.

18% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2024

By product

Long Term Care Insurance 60%
Life and Annuities Segment 21%
Life Insurance 18%
Corporate and Other 0.3%
Fixed Annuities 0.2%

By region

Australia Mortgage Insurance 100%

Long Term Care Insurance brings in 60% of revenue. Corporate and Other grew fastest, by 12% a year.

Segments in detail